Literature DB >> 4640856

Route of administration and drug metabolism.

M Gibaldi, S Feldman.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 4640856     DOI: 10.1016/0014-2999(72)90098-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  8 in total

1.  Assuming peripheral elimination: its impact on the estimation of pharmacokinetic parameters of muscle relaxants.

Authors:  J Laurin; F Nekka; F Donati; F Varin
Journal:  J Pharmacokinet Biopharm       Date:  1999-10

2.  Pharmacokinetics of diphenhydramine in man.

Authors:  K S Albert; M R Hallmark; E Sakmar; D J Weidler; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1975-06

3.  Quantitation of hepatic and pulmonary first-pass effects and its implications in pharmacokinetic study. I. Pharmacokinetics of chloroform in man.

Authors:  W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1975-06

4.  Ergot alkaloids: hepatic distribution and estimation of absorption by measurement of total radioactivity in bile and urine.

Authors:  F Nimmerfall; J Rosenthaler
Journal:  J Pharmacokinet Biopharm       Date:  1976-02

5.  Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans.

Authors:  P H Hinderling; E R Garrett
Journal:  J Pharmacokinet Biopharm       Date:  1976-06

6.  Plasma levels of imipramine and desipramine in man after different routes of administration.

Authors:  A Nagy; R Johansson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

7.  Oral prednisone for chronic active liver disease: dose responses and bioavailability studies.

Authors:  M Uribe; S W Schalm; W H Summerskill; V L Go
Journal:  Gut       Date:  1978-12       Impact factor: 23.059

8.  The pharmacokinetics of neostigmine and 3-hydroxyphenyltrimethyl- ammonium in the rat: dose-dependent effects after portal vein administration.

Authors:  H E Barber; G R Bourne
Journal:  Br J Pharmacol       Date:  1974-12       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.